ABOSAcumen Pharmaceuticals Inc. Common Stock
3.160USD+0.32%Mkt Cap: 228.52M $P/E: —3d ago
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap228.52M $
Enterprise Value152.14M $
Revenue (TTM)—
Gross Profit-86.79M $
Net Income (TTM)-121.33M $
Revenue/Share—
Last Price3.160 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees60
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.23
PEG—
EV/EBITDA-1.44
EV/Revenue—
P/S—
P/B4.03
EPS (TTM)-1.66
EPS (Forward)-1.43
52W Range
1.19082% of range3.600
52W High3.600 USD
52W Low1.190 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-172.28%
ROA-98.78%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-115.54M $
CapEx (TTM)88.00K $
FCF Margin—
FCF Yield-24.73%
Net Debt-78.55M $
Net Debt/EBITDA0.75
Balance Sheet
Debt/Equity0.44
Current Ratio2.47
Quick Ratio2.38
Book Value/Sh0.7920 USD
Cash/Share1.524 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.400 USD
Upside (mean)+134.2%
Target Range4.000 USD – 10.00 USD
$4.000+134.2% to mean$10.00
# Analysts5
Ownership
Shares Out.72.32M
Float37.05M
Insiders6.79%
Institutions66.58%
Short Interest
Short Ratio8.8d
Short % Float6.69%
Short % Out.4.66%
Shares Short3.37M
Short (prev mo.)2.79M
Technical
SMA 502.426 (+30.3%)
SMA 2002.380 (+32.7%)
Beta0.33
S&P 52W Chg18.16%
Avg Vol (30d)398.71K
Avg Vol (10d)405.84K
Technical Indicators
RSI (14)77.0
MACD0.1524
MACD Signal0.0522
MACD Hist.+0.1002
BB Upper3.022 USD
BB Middle2.400 USD
BB Lower1.778 USD
BB Width51.87%
ATR (14)0.1807 USD
Vol Ratio (20d)2.03x